Quest Diagnostics

Patheon

Patheon files registration for Initial Public Offering

Wednesday, June 10, 2015 11:16 AM

Patheon, a CRO based in Durham, N.C., has filed a registration statement with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.

More... »


Perrigo acquires Patheon's Mexican operations for $34 million in cash

Wednesday, May 13, 2015 11:54 AM

Perrigo, a consumer goods and pharmaceutical company headquartered in Ireland, has acquired the Mexican operations of Durham, N.C.-based Patheon for $34 million in cash.  The acquisition is expected to be immediately accretive to calendar 2015 adjusted EPS after the exclusion of estimates for intangible amortization and transaction-related costs.

More... »


Patheon to acquire IRIX Pharmaceuticals

Wednesday, March 18, 2015 01:26 PM

Patheon will acquire IRIX Pharmaceuticals of Florence, S.C., which specializes in difficult to manufacture Active Pharmaceutical Ingredient (API) needs for drugs from early and late development through commercial launch. Patheon expects to close the transaction in the next 60 days.

More... »

DPx to expand facility in North Carolina, add 488 jobs

Thursday, October 9, 2014 08:00 AM

DPx, the “umbrella name” for Patheon’s three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies, will expand operations in Pitt County, N.C. The company plans to create 488 jobs in Greenville, N.C. by the end of 2019 and invest $159 million to increase the site’s capabilities, as well as modernize the site and develop energy efficiency programs at the facility.

More... »

Pharma & Biopharma Outsourcing Association formed

Monday, September 29, 2014 01:14 PM

Fifteen contract manufacturing organizations and contract development and manufacturing organizations (CMOs/CDMOs) have joined the Pharma & Biopharma Outsourcing Association (PBOA), a new nonprofit trade association that aims to help advance the industry's regulatory, legislative and business interests. 

More... »

DPx launched by JLL Partners, Royal DSM

Wednesday, March 12, 2014 01:43 PM

JLL Partners and Royal DSM have launched DPx Holdings, a global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

More... »

Royal DSM, JLL create jointly owned CDMO

Wednesday, November 20, 2013 12:48 PM

JLL Partners, a middle-market private equity firm, and Royal DSM, a global life sciences and materials sciences company, have created a new global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of around $2 billion. It will be 51% owned by JLL and 49% owned by DSM.

More... »

Aesica appoints two business development managers

Monday, July 15, 2013 01:32 PM

Aesica, a global contract development and manufacturing organization (CDMO), has appointed Sven Thomas and David Ross business development managers. They will ensure potential customers are aware of how their manufacturing and development needs can be supported.

More... »

Patheon increases investment in Milton Park, U.K. facility

Monday, February 4, 2013 12:27 PM

Patheon, a provider of contract development and commercial manufacturing services, has announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, U.K., Milton Park is a dedicated pharmaceutical development services facility focused on early development projects.

More... »

Patheon to acquire Banner Pharmacaps

Tuesday, October 30, 2012 10:24 AM

Patheon, a Durham, N.C.-based provider of contract development and manufacturing services, has signed a definitive agreement with Vion, a global manufacturer of foodstuffs and ingredients based in the Netherlands, to acquire Banner Pharmacaps, a High Point, N.C.-based specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs